Skip to main content
Premium Trial:

Request an Annual Quote

Pelican Life Sciences Secures $100M in VC Cash; Closes First Acquisition, Plans More

NEW YORK, April 25 (GenomeWeb News) - Nascent reagent shop Pelican Life Sciences has raised $100 million in private equity for acquisitions and development, the company said yesterday.


The company also said that it has completed its first acquisition of PML Microbiologicals, which it originally announced in December.


The firm will use the cash to acquire "premier companies with proven track records of providing high-quality, differentiated products to support the pharmaceutical, biotech, and academic research markets," Pelican said in a statement.


Pelican also said that it would use the money to support product development, streamline manufacturing operations, and expand sales and marketing in its acquired entities.


Headquartered in Charlotte, NC, Pelican provides products for discovery and detection, including life science reagents and consumables targeted to the microbiology and molecular biology markets.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.